olmesartan has been researched along with Extrasystole, Ventricular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirose, M; Kashihara, T; Matsushita, N; Mende, U; Nakada, T; Sanbe, A; Shimojo, H; Suzuki, S; Taira, E; Takeishi, Y; Yamada, M | 1 |
1 other study(ies) available for olmesartan and Extrasystole, Ventricular
Article | Year |
---|---|
Cardiac overexpression of constitutively active Galpha q causes angiotensin II type1 receptor activation, leading to progressive heart failure and ventricular arrhythmias in transgenic mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Atrial Natriuretic Factor; Collagen Type I; Disease Models, Animal; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Imidazoles; Mice; Mice, Transgenic; Myosin Heavy Chains; Tetrazoles; Ventricular Premature Complexes | 2014 |